• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Metabolon

edit

Metabolon, Inc., a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. The company provides biochemical markers and information for understanding biochemical processes, such as drug action, toxicology, and bioprocess monitoring. Its metabolomics platform is used to develop diagnostics for cancer, amyotropic lateral sclerosis, diabetes, and metabolic diseases. The company was founded in 2000 and is based in Durham, North Carolina.

Milestones

edit

• 
  Metabolon added Paul Schimmel as Co-Founder and Member of Scientific Advisory Board .
  Posted 12/7/09 at 9:47pm
• 
  Metabolon added S. Todd Lynch as CFO.
  Posted 12/7/09 at 9:47pm
• 
  Metabolon added John A. Ryals as CEO.
  Posted 12/7/09 at 9:47pm
• 
  Metabolon received $13.1M in Series D funding. (8/29/11)
  Posted 8/29/11 at 6:53pm via finsmes.com
• 
  Metabolon received $8M in Series B funding. (1/18/06)
  Posted 4/23/10 at 11:22pm via accessmylibrary.com
• 
  Metabolon received $6M in Series C funding. (12/7/09)
  Posted 12/7/09 at 9:47pm via onbiovc.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 12/8/09

Sources

1. Metabolon Closes $8 Million Series B Funding Round (accessmylibrary.com) [edit]
2. Metabolon, Inc.: Series C $6M (onbiovc.com) [edit]
3. Metabolon Secures $13.1M in Series D Financing (finsmes.com) [edit]